North America Inhalable Drugs Market Key Factors
Published: Nov 2020
The North American inhalable drug market is anticipated to grow at a CAGR of 2.8% over the forecast period (2020-2026). The key factors that drive the growth of the inhalable drugs industry is the rising prevalence of various respiratory and non- respiratory diseases that create the demand for inhalable drugs.
Europe Inhalable Drugs Market Key Factors
Published: Nov 2020
The European inhalable drug market is anticipated to grow at a CAGR of 3.3% over the forecast period (2020-2026). The key factors that drive the growth of the market include the support by the key players functioning in the market, rising geriatric population, sedentary lifestyles, along with the change in eating habits of the people.
Prevalence of Respiratory Diseases to Accelerate Asia-Pacific Inhalable Drugs Market
Published: Nov 2020
The Asia-Pacific inhalable drug market is anticipated to grow at a CAGR of 5.1% over the forecast period (2020-2026). The key factors that drive the growth of the market include the rising prevalence of asthmatic patients across the region, especially in China.
Rising level of air pollution gives rise to various diseases and hence creates demand for inhalable drugs
Published: Nov 2020
The US inhalable drug market is anticipated to grow at a CAGR of 2.3% over the forecast period (2020-2026). The key factors that drive the growth of the industry include the increased prevalence of respiratory diseases such as asthma, COPD among others.
Rising Prevalence of Respiratory and Non- Respiratory Diseases to Drive UK Inhalable Drugs Market
Published: Nov 2020
The UK inhalable drug market is anticipated to grow at a CAGR of 2.0% over the forecast period (2020-2026). The key aspect that drives the growth of the market includes the rising prevalence of various respiratory and non- respiratory diseases and the increasing geriatric population.
Presence of key market players is escalating the US Geriatric Medicine Market
Published: Nov 2020
The US geriatric medicine market is projected to grow at a CAGR of 4.6% during the forecast period (2020-2026). The US has high per capita income, access to advanced healthcare, a large elderly population, and a high prevalence of chronic diseases are some of the major factors driving the geriatric medicine market in the country.
Emphasis on catering the healthcare solutions for the rising elderly population is escalating the UK Geriatric Medicine Market
Published: Nov 2020
UK geriatric medicine market is projected to grow at a significant CAGR during the forecast period (2020-2026). Geriatric medicine is one of the largest specialties in the UK. It offers a thought-provoking intellectual challenge, which includes illness that presents in unusual ways in older people.
Developed healthcare infrastructure drives the North America Geriatric Medicine Market
Published: Nov 2020
The North American geriatric medicine market is projected to grow at a CAGR of 4.9% during the forecast period (2020-2026). The healthcare expenditure rate of North America is high on R&D and there is more business opportunity in the US as compared to Canada.
Government Support for elderly care is escalating the India Geriatric Medicine Market
Published: Nov 2020
The Indian geriatric medicine market is projected to grow at a significant CAGR of 8.1% during the forecast period (2020-2026). The Government of India has been focusing on issues, such as maternal and child health, population stabilization, and elderly health.
The establishment of programs and research centers for elderly health is escalating the European Geriatric Medicine Market
Published: Nov 2020
The European geriatric medicine market is projected to grow at a CAGR of 5.4% during the forecast period (2020-2026). Geriatric medicine is fostering in Europe with the rising burden of healthcare disorders in elderly people.